Literature DB >> 28107216

Analysis of Central and Peripheral Vision Reaction Times in Patients With Postconcussion Visual Dysfunction.

Joseph F Clark1, James K Ellis, Timothy M Burns, John M Childress, Jon G Divine.   

Abstract

OBJECTIVE: To determine whether central and peripheral vision reaction times (PVRTs) are prolonged in patients with visual dysfunction after sustaining a concussion.
DESIGN: Comparison of Dynavision D2 central and PVRTs in patients with postconcussion visual dysfunction were compared with control data from a normative patient database. Concussion patients without visual dysfunction were not included in this study.
SETTING: National Collegiate Athletic Association Division 1 college training room and university based, academic health center. PARTICIPANTS: Patients were selected for inclusion based on diagnosis of new visual dysfunction as indicated either by physical examination of the team physician or by patient self-report of symptoms. Patients included college athletes, college students, and concussion patient's presenting to a university based, academic health center. INTERVENTION: Measurement of central and PVRTs using a Dynavision D2 reaction time program were used as the dependent variables. Evaluations were conducted from 3 days to 11 months postconcussion, depending on the temporal development of visual symptoms after the concussion. No intervention was used. MAIN OUTCOME MEASURES: Average central and PVRTs for patients with postconcussion visual symptoms were compared with an asymptomatic control group with no history of concussion.
RESULTS: Both central and PVRTs were significantly prolonged in patients with postconcussion visual symptoms compared with patients with no history of concussion.
CONCLUSIONS: Central and PVRTs are both prolonged in patients with postconcussion visual dysfunction with PVRT being disproportionately prolonged. The percent change from central to PVRT was also increased in patients with postconcussion visual dysfunction.

Entities:  

Mesh:

Year:  2017        PMID: 28107216     DOI: 10.1097/JSM.0000000000000381

Source DB:  PubMed          Journal:  Clin J Sport Med        ISSN: 1050-642X            Impact factor:   3.638


  6 in total

1.  Risk Factors for Initial and Subsequent Core or Lower Extremity Sprain or Strain Among Collegiate Football Players.

Authors:  Alexandra A McDonald; Gary B Wilkerson; Brendon P McDermott; Jeffrey A Bonacci
Journal:  J Athl Train       Date:  2019-05-14       Impact factor: 2.860

2.  Dynavision Normative Data for Healthy Adults: Reaction Test Program.

Authors:  Cherie Blackwell; Kathy Cary; Kami Holst; Kristen Mandle; Lori Dryg; Susan Clemens; Jon H Lemke; Sarah Castro; Emma Hendricks; Ryan Kelly
Journal:  Am J Occup Ther       Date:  2020 Jan/Feb

3.  Relationship Between the King-Devick Test and Commonly Used Concussion Tests at Baseline.

Authors:  James R Clugston; Zachary M Houck; Breton M Asken; Jonathan K Boone; Anthony P Kontos; Thomas A Buckley; Julianne D Schmidt; Sara P D Chrisman; Nicole L Hoffman; Kimberly G Harmon; Thomas W Kaminski; Michael W Collins; Thomas W McAllister; Michael A McCrea; Steven P Broglio; Justus D Ortega
Journal:  J Athl Train       Date:  2019-10-04       Impact factor: 2.860

4.  The use of a visual motor test to identify lingering deficits in concussed collegiate athletes.

Authors:  Katherine J Hunzinger; Erik W Sanders; Horace E Deal; Jody L Langdon; Kelsey M Evans; Brandy A Clouse; Barry A Munkasy; Thomas A Buckley
Journal:  J Clin Transl Res       Date:  2020-04-16

5.  Reliability of the Dynavision task in virtual reality to explore visuomotor phenotypes.

Authors:  Yvan Pratviel; Veronique Deschodt-Arsac; Florian Larrue; Laurent M Arsac
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

6.  The Effect of Concussion History on Lower Extremity Injury Risk in College Athletes: A Systematic Review and Meta-Analysis.

Authors:  Ryan McCann; Eric Schussler; Jessica Martinez; Vanessa Ramirez
Journal:  Int J Sports Phys Ther       Date:  2022-08-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.